{"title":"Abstract IACC0601: Radiopharmaceuticals and their future in cancer care","authors":"C. Kunos","doi":"10.1158/1535-7163.targ-21-iacc0601","DOIUrl":"https://doi.org/10.1158/1535-7163.targ-21-iacc0601","url":null,"abstract":"","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130087660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract IA15: Suppression of intratumoral regulatory T cells restores radiosensitivity in head and neck cancer: Role for Stat3 inhibition","authors":"S. Karam","doi":"10.1158/1557-3265.aacrahns19-ia15","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia15","url":null,"abstract":"","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126564983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract IA14: Targeting the DNA damage response in head and neck cancers","authors":"T. Yap","doi":"10.1158/1557-3265.aacrahns19-ia14","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia14","url":null,"abstract":"The discovery that BRCA1/2 mutant cancer cells are exquisitely sensitive to inhibition of poly(ADP-ribose) polymerase (PARP) has ushered in a new era of research on biomarker-driven synthetic lethal treatment strategies for different cancers. The therapeutic landscape of antitumor agents targeting the DNA damage response (DDR) has rapidly expanded to include inhibitors of other key mediators of DNA repair and replication, such as ATM, ATR, CHK1 and CHK2, DNA-PK, and WEE1. Efforts to optimize these therapies are ongoing across a range of cancers, including head and neck cancer. These approaches have involved evaluation of molecular predictive biomarker of response beyond BRCA1/2 mutations, and the development of rational, tolerable combinations with novel molecularly targeted agents to create a BRCAness phenotype, other DDR inhibitors, and immune-checkpoint inhibitors. Citation Format: Timothy A. Yap. Targeting the DNA damage response in head and neck cancers [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; 2019 Apr 29-30; Austin, TX. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(12_Suppl_2):Abstract nr IA14.","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"200 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115633325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract IA12: Metabolic barriers to effective immunotherapy of cancer","authors":"Greg M. Delgoffe","doi":"10.1158/1557-3265.aacrahns19-ia12","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia12","url":null,"abstract":"The tumor microenvironment presents a number of barriers to antitumor immunity, both immunologic and nonimmunologic in nature. It is now appreciated that, driven by the deregulated energetics of the cancer cells, the tumor microenvironment possesses a distinct metabolic landscape that may be detrimental to immune function, thus acting as a resistance mechanism to immunotherapy. I will discuss the metabolic defects present in tumor-infiltrating T cells and highlight the mechanistic underpinnings that drive these deficiencies. Further, I will discuss how genetic engineering, pharmacologic intervention, and costimulatory immunotherapy can be employed to modulate the metabolism of infiltrating T cells. Finally, I will describe how profiling the metabolism of patient tumor cells can yield insight into the regulation of immunity and the response to immunotherapy. Citation Format: Greg M. Delgoffe. Metabolic barriers to effective immunotherapy of cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; 2019 Apr 29-30; Austin, TX. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(12_Suppl_2):Abstract nr IA12.","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124746244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract IA17: Cellular interactions and regulatory mechanisms in head and neck cancer","authors":"D. Vignali","doi":"10.1158/1557-3265.aacrahns19-ia17","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia17","url":null,"abstract":"","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130675356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Powell, R. Leone, M. Oh, R. Rais, P. Majer, B. Slusher
{"title":"Abstract IA10: Targeting glutamine metabolism as a means of enhancing immunotherapy for cancer","authors":"J. Powell, R. Leone, M. Oh, R. Rais, P. Majer, B. Slusher","doi":"10.1158/1557-3265.aacrahns19-ia10","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia10","url":null,"abstract":"Tumors possess specialized metabolic programming that facilitates their rapid growth. We have developed a novel glutamine antagonist that not only demonstrates single-agent efficacy in a variety of mouse tumor models but also synergizes with anti-PD-1, adoptive cellular therapy (ACT), and A2aR antagonism to overcome resistance to immunotherapy and promote durable cures. Our data demonstrate that targeting tumor glutamine metabolism alters the tumor microenvironment by making it less acidic, less hypoxic, and more nutrient replete. These alterations lead to enhanced endogenous antitumor responses (in the absence of additional immunotherapy). Further analysis of tumor-infiltrating lymphocyte (TIL) reveals markedly increased infiltration of CD8+ T cells with increased proliferative index (Ki67) and the generation of robust memory phenotypes in the treated mice. Further, RNA sequencing data revealed that CD8+ TIL from vehicle-treated mice showed significantly enhanced expression of apoptotic transcriptional programs compared with TIL from treated mice. Additionally, targeting glutamine metabolism leads to decreased MDSC with an increase in inflammatory TAMs. Furthermore, we observe a downregulation of IDO and a marked decrease in kynurenine in the tumors of treated mice. These changes in macrophage subsets also correlated with decreased metastasis. Overall our findings suggest a novel “metabolic” approach to enhancing immunotherapy for cancer. Citation Format: Jonathan Powell, Robert Leone, Min-Hee Oh, Rana Rais, Pavel Majer, Barbara Slusher. Targeting glutamine metabolism as a means of enhancing immunotherapy for cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; 2019 Apr 29-30; Austin, TX. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(12_Suppl_2):Abstract nr IA10.","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121498016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract IA08: Understanding programs of invasion and metastasis in head and neck cancer","authors":"Sidharth V. Puram","doi":"10.1158/1557-3265.aacrahns19-ia08","DOIUrl":"https://doi.org/10.1158/1557-3265.aacrahns19-ia08","url":null,"abstract":"","PeriodicalId":361983,"journal":{"name":"Oral Presentations - Invited Abstracts","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124483401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}